NCT00124397View on ClinicalTrials.gov

Atorvastatin and Endothelial Function in Type 2 Diabetes Mellitus (ATTEND-Study)

PHASE4CompletedINTERVENTIONAL
Enrollment

186

Participants

Timeline

Start Date

July 31, 2001

Study Completion Date

December 31, 2004

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Atorvastatin

Trial Locations (1)

5700

Department of Medical Research, SHF Svendborg

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

University of Southern Denmark

OTHER

NCT00124397 - Atorvastatin and Endothelial Function in Type 2 Diabetes Mellitus (ATTEND-Study) | Biotech Hunter | Biotech Hunter